SI Septerna, Inc. Stock: price and directors' dealings · United States · SEC (Form 4) Follow the Septerna, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was reported on 5 August 2026 (Levée d'options). Among the most active insiders: Bhatt Elizabeth. Every trade is free.
€355,702
7 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate Septerna, Inc. Strong Buy (bullish), based on 9 analysts. Average price target: US$45.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
Generate AI analysis AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 August 2026
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
◇ SVP, Drug Discovery · Executives · 3 Aug 2026
1,816 shares @ US$2.76 Common Stock SEC:0001193125-26-335820:0
◇ SVP, Drug Discovery · Executives · 3 Aug 2026
1,518 shares @ US$2.76 Common Stock SEC:0001193125-26-335820:1
▼ SVP, Drug Discovery · Executives · 3 Aug 2026
1,000 shares @ US$33.9756 Common Stock SEC:0001193125-26-335820:2
▼ SVP, Drug Discovery · Executives · 3 Aug 2026
2,334 shares @ US$34.6805 Common Stock SEC:0001193125-26-335820:3
◇ President and COO · Executives · 15 Jul 2026
4,000 shares @ US$6.81 0.0018% mcap 8.8% of flow Common Stock SEC:0001193125-26-308073:0
▼ President and COO · Executives · 15 Jul 2026
4,000 shares @ US$33.9935 0.0089% mcap 43.8% of flow Common Stock SEC:0001193125-26-308073:1
● Officer · Executives · 15 Jul 2026
4,000 shares @ US$34.54 0.0090% mcap 100.0% of flow Common SEC144:0001950047-26-007101
● Officer · Executives · 26 Jun 2026
2,438 shares @ US$36.605 0.0053% mcap 100.0% of flow Common SEC144:0001950047-26-006526
● Officer · Executives · 22 Jun 2026
94,339 shares @ US$35.2571 0.20% mcap 97.4% of flow Common SEC144:0001950047-26-006351
● Officer · Executives · 22 Jun 2026
25,000 shares @ US$36.17 0.056% mcap 100.0% of flow Common SEC144:0001950047-26-006361
● Officer · Executives · 12 Jun 2026
8,428 shares @ US$34.03 0.017% mcap 100.0% of flow Common SEC144:0001950047-26-006015
◇ President and COO · Executives · 15 Apr 2026
4,000 shares @ US$6.81 0.0016% mcap 21.9% of flow Common Stock SEC:0001193125-26-161987:0
▼ President and COO · Executives · 15 Apr 2026
2,573 shares @ US$23.7558 0.0037% mcap 49.1% of flow Common Stock SEC:0001193125-26-161987:1
▼ President and COO · Executives · 15 Apr 2026
1,101 shares @ US$25.2394 0.0017% mcap 22.3% of flow Common Stock SEC:0001193125-26-161987:2
▼ President and COO · Executives · 15 Apr 2026
326 shares @ US$25.8623 0.0005% mcap 6.8% of flow Common Stock SEC:0001193125-26-161987:3
◇ Chief People Officer · Executives · 2 Mar 2026
53,714 shares @ US$1.55 100.0% of flow Common Stock SEC:0001193125-26-092050:0
◇ President and COO · Executives · 18 Feb 2026
4,000 shares @ US$6.81 17.9% of flow Common Stock SEC:0001193125-26-061675:0
▼ SVP, Drug Discovery · Executives · 10 Nov 2025
3,501 shares @ US$18.0586 100.0% of flow Common Stock SEC:0001193125-25-280756:0
◇ SVP, Biological Sciences · Executives · 18 Aug 2025
10,452 shares @ US$2.76 100.0% of flow Common Stock SEC:0000950170-25-110177:0
◇ CEO and President · Executives · 2 Apr 2025
50,000 shares @ US$2.76 70.0% of flow Common Stock SEC:0000950170-25-051135:0
▲ Director · Executives · 7 Mar 2025
13,319 shares @ US$6.9277 65.4% of flow Common Stock SEC:0000950170-25-036321:0
Canonical exit: 5 Jun 2025 (T+90) ▲ Director · Executives · 4 Mar 2025
7,491 shares @ US$6.3468 34.6% of flow Common Stock SEC:0000950170-25-035064:0
Canonical exit: 2 Jun 2025 (T+90) ▲ CEO and President · Executives · 25 Feb 2025
10,000 shares @ US$5.6765 30.0% of flow Common Stock SEC:0000950170-25-029332:0
Canonical exit: 26 May 2025 (T+90) ▲ Chief Financial Officer · Executives · 25 Feb 2025
6,282 shares @ US$5.59 37.8% of flow Common Stock SEC:0000950170-25-029330:0
Canonical exit: 26 May 2025 (T+90) 18,861 shares @ US$5.999 3.0% of flow Common Stock SEC:0000950170-25-027754:0
Canonical exit: 25 May 2025 (T+90) 25 of 29 declarations
Load more (4 remaining) About Septerna, Inc. Septerna, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions in the biotechnology sector.